Next report date
Report period
H1 2024
EPS estimate
−0.37HKD
Revenue estimate
12.61 MHKD
−0.79HKD
−425.47 MHKD
20.72 MHKD
510.71 M
About ZHAOKE OPHTHALMOLOGY LTD
Sector
CEO
Xiao Yi Li
Headquarters
Guangzhou
Website
Employees (FY)
313
Founded
2017
ISIN
KYG989M51017
FIGI
BBG010498PX4
Zhaoke Ophthalmology Ltd. operates as holding company, which engages in the provision of ophthalmic pharmaceuticals. It focuses on the research, development, and commercialization of therapies and ophthalmic drugs. The company was founded in January 2017 and is headquartered in Guangzhou, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 6622 is 1.51 HKD — it has decreased by 1.95% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange ZHAOKE OPHTHALMOLOGY LTD stocks are traded under the ticker 6622.
ZHAOKE OPHTHALMOLOGY LTD is going to release the next earnings report on Aug 21, 2024. Keep track of upcoming events with our Earnings Calendar.
6622 stock is 4.03% volatile and has beta coefficient of 1.10. Check out the list of the most volatile stocks — is ZHAOKE OPHTHALMOLOGY LTD there?
6622 earnings for the last quarter are −0.46 HKD per share, whereas the estimation was −0.44 HKD resulting in a −4.88% surprise. The estimated earnings for the next quarter are −0.56 HKD per share. See more details about ZHAOKE OPHTHALMOLOGY LTD earnings.
ZHAOKE OPHTHALMOLOGY LTD revenue for the last quarter amounts to 12.22 M HKD despite the estimated figure of 2.59 M HKD. In the next quarter revenue is expected to reach 11.30 M HKD.
Yes, you can track ZHAOKE OPHTHALMOLOGY LTD financials in yearly and quarterly reports right on TradingView.
6622 stock has fallen by 3.21% compared to the previous week, the month change is a 3.21% fall, over the last year ZHAOKE OPHTHALMOLOGY LTD has showed a 60.78% decrease.
6622 net income for the last quarter is −163.41 M HKD, while the quarter before that showed −264.39 M HKD of net income which accounts for 38.19% change. Track more ZHAOKE OPHTHALMOLOGY LTD financial stats to get the full picture.
Today ZHAOKE OPHTHALMOLOGY LTD has the market capitalization of 841.05 M, it has decreased by 0.64% over the last week.
No, 6622 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 6622 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ZHAOKE OPHTHALMOLOGY LTD stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 313.00 employees. See our rating of the largest employees — is ZHAOKE OPHTHALMOLOGY LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ZHAOKE OPHTHALMOLOGY LTD technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ZHAOKE OPHTHALMOLOGY LTD stock shows the sell signal. See more of ZHAOKE OPHTHALMOLOGY LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ZHAOKE OPHTHALMOLOGY LTD future price: according to them, 6622 price has a max estimate of 3.44 HKD and a min estimate of 3.44 HKD. Read a more detailed ZHAOKE OPHTHALMOLOGY LTD forecast: see what analysts think of ZHAOKE OPHTHALMOLOGY LTD and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ZHAOKE OPHTHALMOLOGY LTD EBITDA is −450.03 M HKD, and current EBITDA margin is −2.17 K%. See more stats in ZHAOKE OPHTHALMOLOGY LTD financial statements.